Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies

Cardiovascular Research

Volumn 70, Issue 2, 2006, Pages 231-239

  Cohen, Michael V ^a   Yang, Xi Ming ^a   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Carbon monoxide; Cardioprotection; Natriuretic peptide; Nitric oxide; Phosphodiesterase inhibitor; Preconditioning; Statin

Indexed keywords

ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ACETYLSALICYLIC ACID 4 NITROXYBUTYL ESTER; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; DIAZOXIDE; FLUINDOSTATIN; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N ACETYL S NITROSOPENICILLAMINE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRITE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE V INHIBITOR; POTASSIUM CHANNEL; REACTIVE OXYGEN METABOLITE; RUTHENIUM DERIVATIVE; SILDENAFIL; SIMVASTATIN;

APOPTOSIS; CELL DEATH; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ERECTILE DYSFUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTENSION; ISCHEMIC PRECONDITIONING; LEUKOCYTE ADHERENCE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RECEPTOR BLOCKING; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION INHIBITION; TRANSACTIVATION; UPREGULATION;

ADENOSINE; ANIMALS; CARBON MONOXIDE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NATRIURETIC PEPTIDES; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 33646489779     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.10.021     Document Type: Review

References (78)

1. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
2. ATP channel. Annu Rev Physiol 62 (2000) 79-109
3. Cohen M.V., and Downey J.M. Ischemic preconditioning: description, mechanism, and significance. In: Sperelakis N., Kurachi Y., Terzic A., and Cohen M.V. (Eds). Heart physiology and pathophysiology. Fourth Edition (2001), Academic Press, San Diego 867-885
4. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33 (2001) 1897-1918
5. Woolfson R.G., Patel V.C., Neild G.H., and Yellon D.M. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91 (1995) 1545-1551
6. Lochner A., Marais E., Genade S., and Moolman J.A. Nitric oxide: a trigger for classic preconditioning?. Am J Physiol 279 (2000) H2752-H2765
7. Ferdinandy P., Szilvássy Z., Horváth L.I., Csont T., Csonka C., Nagy E., et al. Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol 29 (1997) 3321-3333
8. Nakano A., Liu G.S., Heusch G., Downey J.M., and Cohen M.V. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol 32 (2000) 1159-1167
9. ATP-dependent mechanism. Am J Physiol 287 (2004) H712-H718
10. Forbes R.A., Steenbergen C., and Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 88 (2001) 802-809
11. Yao Z., Tong J., Tan X., Li C., Shao Z., Kim W.C., et al. Role of reactive oxygen species in acetylcholine-induced preconditioning in cardiomyocytes. Am J Physiol 277 (1999) H2504-H2509
12. ATP channels triggers the preconditioned state by generating free radicals. Circ Res 87 (2000) 460-466
13. Krieg T., Cui L., Qin Q., Cohen M.V., and Downey J.M. Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF. J Mol Cell Cardiol 36 (2004) 435-443
14. ATP channel opening. J Mol Cell Cardiol 35 (2003) 653-660
15. i proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc Res 55 (2002) 544-552
16. Krieg T., Qin Q., Philipp S., Alexeyev M.F., Cohen M.V., and Downey J.M. Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. Am J Physiol 287 (2004) H2606-H2611
17. ATP channel opening and leads to cardioprotection. Am J Physiol 286 (2004) H468-H476
18. Krieg T., Qin Q., McIntosh E.C., Cohen M.V., and Downey J.M. ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases. Am J Physiol 283 (2002) H2322-H2330
19. 5-enkephalin-induced cardioprotection occurs via transactivation of EGFR and activation of PI3K. Am J Physiol 288 (2005) H1955-H1964
20. Krieg T., Landsberger M., Alexeyev M.F., Felix S.B., Cohen M.V., and Downey J.M. Activation of Akt is essential for acetylcholine to trigger generation of oxygen free radicals. Cardiovasc Res 58 (2003) 196-202
21. Fulton D., Gratton J.-P., McCabe T.J., Fontana J., Fujio Y., Walsh K., et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 (1999) 597-601
22. Costa A.D.T., Garlid K.D., West I.C., Lincoln T.M., Downey J.M., Cohen M.V., et al. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97 (2005) 329-336
23. + channel in cardiac function and cardioprotection. Biochim Biophys Acta 1606 (2003) 1-21
24. Baines C.P., Goto M., and Downey J.M. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 29 (1997) 207-216
25. Tritto I., D'Andrea D., Eramo N., Scognamiglio A., De Simone C., Violante A., et al. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 80 (1997) 743-748
26. Hausenloy D.J., Tsang A., Mocanu M.M., and Yellon D.M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol 288 (2005) H971-H976
27. Solenkova NV, Solodushko V, Cohen MV, Downey JM. Endogenous adenosine protects the preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol; 290 [in press].
28. Hausenloy D.J., Yellon D.M., Mani-Babu S., and Duchen M.R. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol 287 (2004) H841-H849
29. ATP channels. Circ Res 89 (2001) 273-278
30. Peart J., and Headrick J.P. Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects. Cardiovasc Res 58 (2003) 589-601
31. Nossuli T.O., Hayward R., Scalia R., and Lefer A.M. Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation 96 (1997) 2317-2324
32. Williams M.W., Taft C.S., Ramnauth S., Zhao Z.-Q., and Vinten-Johansen J. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc Res 30 (1995) 79-86
33. Hoshida S., Yamashita N., Igarashi J., Nishida M., Hori M., Kamada T., et al. Nitric oxide synthase protects the heart against ischemia-reperfusion injury in rabbits. J Pharmacol Exp Ther 274 (1995) 413-418
34. Pabla R., Buda A.J., Flynn D.M., Blessé S.A., Shin A.M., Curtis M.J., et al. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res 78 (1996) 65-72
35. Brunner F., Maier R., Andrew P., Wölkart G., Zechner R., and Mayer B. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res 57 (2003) 55-62
36. Jones S.P., Greer J.J.M., Kakkar A.K., Ware P.D., Turnage R.H., Hicks M., et al. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol 286 (2004) H276-H282
37. Kanno S., Lee P.C., Zhang Y., Ho C., Griffith B.P., Shears II L.L., et al. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation 101 (2000) 2742-2748
38. Sharp B.R., Jones S.P., Rimmer D.M., and Lefer D.J. Differential response to myocardial reperfusion injury in eNOS-deficient mice. Am J Physiol 282 (2002) H2422-H2426
39. Nakanishi K., Vinten-Johansen J., Lefer D.J., Zhao Z., Fowler III W.C., McGee D.S., et al. Intracoronary l-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 263 (1992) H1650-H1658
40. Weyrich A.S., Ma X.-l., and Lefer A.M. The role of l-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86 (1992) 279-288
41. Siegfried M.R., Carey C., Ma X.-L., and Lefer A.M. Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol 263 (1992) H771-H777
42. Lefer D.J., Nakanishi K., Johnston W.E., and Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88 (1993) 2337-2350
43. Pabla R., Buda A.J., Flynn D.M., Salzberg D.B., and Lefer D.J. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am J Physiol 269 (1995) H1113-H1121
44. Horimoto H., Saltman A.E., Gaudette G.R., and Krukenkamp I.B. Nitric oxide-generating β-adrenergic blocker nipradilol preserves postischemic cardiac function. Ann Thorac Surg 68 (1999) 844-849
45. Draper N.J., and Shah A.M. Beneficial effects of a nitric oxide donor on recovery of contractile function following brief hypoxia in isolated rat heart. J Mol Cell Cardiol 29 (1997) 1195-1205
46. Mizumura T., Nithipatikom K., and Gross G.J. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res 29 (1995) 482-489
47. Hill M., Takano H., Tang X.-L., Kodani E., Shirk G., and Bolli R. Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation 104 (2001) 694-699
48. Carini M., Aldini G., Orioli M., Piccoli A., Rossoni G., and Facino R.M. Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the rat. Life Sci 74 (2004) 3291-3305
49. Carini M., Aldini G., Orioli M., Piccoli A., Tocchetti P., and Facino R.M. Chemiluminescence and LC-MS/MS analyses for the study of nitric oxide release and distribution following oral administration of nitroaspirin (NCX 4016) in healthy volunteers. J Pharm Biomed Anal 35 (2004) 277-287
50. Rossoni G., Manfredi B., de Gennaro Colonna V., Bernareggi M., and Berti F. The nitroderivative of aspirin, NCX 4016, reduces infarct size caused by myocardial ischemia-reperfusion in the anesthetized rat. J Pharmacol Exp Ther 297 (2001) 380-387
51. Wainwright C.L., Miller A.M., Work L.M., and del Soldato P. NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. Br J Pharmacol 135 (2002) 1882-1888
52. Fiorucci S., Mencarelli A., Meneguzzi A., Lechi A., Renga B., del Soldato P., et al. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. J Am Coll Cardiol 44 (2004) 635-641
53. Duranski M.R., Greer J.J.M., Dejam A., Jaganmohan S., Hogg N., Langston W., et al. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 115 (2005) 1232-1240
54. ATP channels in rabbits. Am J Physiol 283 (2002) H1263-H1269
55. Salloum F., Yin C., Xi L., and Kukreja R.C. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Circ Res 92 (2003) 595-597
56. Das A., Xi L., and Kukreja R.C. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis: essential role of nitric oxide signaling. J Biol Chem 280 (2005) 12944-12955
57. Das S., Maulik N., Das D.K., Kadowitz P.J., and Bivalacqua T.J. Cardioprotection with sildenafil, a selective inhibitor of cyclic 3′,5′-monophosphate-specific phosphodiesterase 5. Drugs Exp Clin Res 28 (2002) 213-219
58. Wright D.G., and Lefer D.J. Statin mediated protection of the ischemic myocardium. Vascul Pharmacol 42 (2005) 265-270
59. Laufs U., La Fata V., Plutzky J., and Liao J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97 (1998) 1129-1135
60. Laufs U., and Liao J.K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273 (1998) 24266-24271
61. Laufs U., La Fata V., and Liao J.K. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem 272 (1997) 31725-31729
62. Kureishi Y., Luo Z., Shiojima I., Bialik A., Fulton D., Lefer D.J., et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6 (2000) 1004-1010
63. Lefer A.M., Campbell B., Shin Y.-K., Scalia R., Hayward R., and Lefer D.J. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation 100 (1999) 178-184
64. Scalia R., Gooszen M.E., Jones S.P., Hoffmeyer M., Rimmer III D.M., Trocha S.D., et al. Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation 103 (2001) 2598-2603
65. Tiefenbacher C.P., Kapitza J., Dietz V., Lee C.-H., and Niroomand F. Reduction of myocardial infarct size by fluvastatin. Am J Physiol 285 (2003) H59-H64
66. Schwartz G.G., and Olsson A.G. The case for intensive statin therapy after acute coronary syndromes. Am J Cardiol 96 Suppl (2005) 45F-53F
67. ATP channel opening. Am J Physiol 284 (2003) H1592-H1600
68. ATP channels [abstract]. J Mol Cell Cardiol 38 (2005) 867
69. McLay J.S., Chatterjee P.K., Jardine A.G., and Hawksworth G.M. Atrial natriuretic factor modulates nitric oxide production: an ANF-C receptor-mediated effect. J Hypertens 13 (1995) 625-630
70. McLay J.S., Chatterjee P.K., Mistry S.K., Weerakody R.P., Jardine A.G., McKay N.G., et al. Atrial natriuretic factor and angiotensin II stimulate nitric oxide release from human proximal tubular cells. Clin Sci 89 (1995) 527-531
71. Zellner C., Protter A.A., Ko E., Pothireddy M.R., DeMarco T., Hutchison S.J., et al. Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries. Am J Physiol 276 (1999) H1049-H1057
72. de los Ángeles Costa M., Elesgaray R., Loria A., Balaszczuk A.M., and Arranz C. Atrial natriuretic peptide influence on nitric oxide system in kidney and heart. Regul Pept 118 (2004) 151-157
73. Asakura M., Jiyoong K., Minamino T., Shintani Y., Asanuma H., Kitakaze M., et al. Rationale and design of a large-scale trial using atrial natriuretic peptide (ANP) as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan Working groups of acute myocardial infarction for the reduction of Necrotic Damage by ANP (J-WIND-ANP). Circ J 68 (2004) 95-100
74. Clark J.E., Naughton P., Shurey S., Green C.J., Johnson T.R., Mann B.E., et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93 (2003) e2-e8
75. Guo Y., Stein A.B., Wu W.-J., Tan W., Zhu X., Li Q.-H., et al. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol 286 (2004) H1649-H1653
76. Fujimoto H., Ohno M., Ayabe S., Kobayashi H., Ishizaka N., Kimura H., et al. Carbon monoxide protects against cardiac ischemia-reperfusion injury in vivo via MAPK and Akt-eNOS pathways. Arterioscler Thromb Vasc Biol 24 (2004) 1848-1853
77. Maulik N., Engelman D.T., Watanabe M., Engelman R.M., Rousou J.A., Flack III J.E., et al. Nitric oxide/carbon monoxide: a molecular switch for myocardial preservation during ischemia. Circulation 94 Suppl II (1996) II-398-II-406
78. Cohen M.V., Yang X.-M., and Downey J.M. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res 74 (1994) 998-1004